These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26391408)
1. Synthesis of two potent glucocorticoid receptor agonists labeled with carbon-14 and stable isotopes. Latli B; Reeves JT; Tan Z; Hrapchak M; Song JJ; Busacca CB; Senanayake CH J Labelled Comp Radiopharm; 2015; 58(11-12):445-52. PubMed ID: 26391408 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of highly potent lymphocyte function-associated antigen-1 antagonists labeled with carbon-14 and with stable isotopes, part 3. Latli B; Hrapchak M; Li G; Lorenz J; Horan J; Busacca CA; Senanayake CH J Labelled Comp Radiopharm; 2019 Feb; 62(2):77-85. PubMed ID: 30466143 [TBL] [Abstract][Full Text] [Related]
3. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium. Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors. Latli B; Hrapchak M; Gorys V; Llinàs-Brunet M; Campbell SS; Song J; Senanayake CH J Labelled Comp Radiopharm; 2014 May; 57(5):350-7. PubMed ID: 24700697 [TBL] [Abstract][Full Text] [Related]
5. Potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 labeled with carbon-13 and carbon-14. Latli B; Hrapchak M; Savoie J; Zhang Y; Busacca CA; Senanayake CH J Labelled Comp Radiopharm; 2017 Jul; 60(9):420-430. PubMed ID: 28494515 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13. Hrapchak M; Latli B; Wang XJ; Lee H; Campbell S; Song JJ; Senanayake CH J Labelled Comp Radiopharm; 2014 Oct; 57(12):687-94. PubMed ID: 25332189 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of isotope-labeled HSP90 inhibitor: [(13) CD3 ] and [(14) C]-TAK-459. Plesescu M; Elliott EL; Li Y; Prakash SR J Labelled Comp Radiopharm; 2014 Jul; 57(9):574-8. PubMed ID: 24992204 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease. Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195 [TBL] [Abstract][Full Text] [Related]
9. Development of a large scale asymmetric synthesis of the glucocorticoid agonist BI 653048 BS H3PO4. Reeves JT; Fandrick DR; Tan Z; Song JJ; Rodriguez S; Qu B; Kim S; Niemeier O; Li Z; Byrne D; Campbell S; Chitroda A; DeCroos P; Fachinger T; Fuchs V; Gonnella NC; Grinberg N; Haddad N; Jäger B; Lee H; Lorenz JC; Ma S; Narayanan BA; Nummy LJ; Premasiri A; Roschangar F; Sarvestani M; Shen S; Spinelli E; Sun X; Varsolona RJ; Yee N; Brenner M; Senanayake CH J Org Chem; 2013 Apr; 78(8):3616-35. PubMed ID: 23544738 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon-13 and carbon-14. Latli B; Hrapchak M; Chevliakov M; Li G; Campbell S; Busacca CA; Senanayake CH J Labelled Comp Radiopharm; 2015 May; 58(6):250-60. PubMed ID: 25964148 [TBL] [Abstract][Full Text] [Related]
11. A short synthesis of d-[1-(14) C]-serine of high enantiomeric purity. Song F; Salter R; Weaner LE J Labelled Comp Radiopharm; 2015 Apr; 58(4):173-6. PubMed ID: 25728900 [TBL] [Abstract][Full Text] [Related]
12. A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium. Latli B; Eriksson M; Hrapchak M; Busacca CA; Senanayake CH J Labelled Comp Radiopharm; 2016 Jun; 59(8):300-4. PubMed ID: 27073120 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE). Ren S; Hesk D; McNamara P; Koharski D; Borges S J Labelled Comp Radiopharm; 2014 Sep; 57(11):632-6. PubMed ID: 25251383 [TBL] [Abstract][Full Text] [Related]
14. Expeditious syntheses of stable and radioactive isotope-labeled anticonvulsant agent, JNJ-26990990, and its metabolites. Lin R; Weaner LE; Hoerr DC; Salter R; Gong Y J Labelled Comp Radiopharm; 2013 Jan; 56(1):22-6. PubMed ID: 24285137 [TBL] [Abstract][Full Text] [Related]
15. Syntheses of [14C]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy]pyridine, a phosphodiesterase 4 inhibitor and its metabolites. Ochi T; Sawayama Y; Kawasaki M; Nigo T; Nakao M; Omodani T; Sumiyoshi T J Labelled Comp Radiopharm; 2014 Jun; 57(7):477-9. PubMed ID: 24966159 [TBL] [Abstract][Full Text] [Related]
16. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors. Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229 [TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis of the D2/3 agonist [3-11C]-(+)-PHNO using [11C]iodomethane. Francisco Garcia-Arguello S; Fortt R; Steel CJ; Brickute D; Glaser M; Turton DR; Robins EG; Arstad E; Luthra SK Appl Radiat Isot; 2013 Mar; 73():79-83. PubMed ID: 23291563 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of carbon-14 and stable isotope labeled Censavudine. Burrell RC; Bonacorsi SJ; Ortiz A; Benkovics T; Shi Z J Labelled Comp Radiopharm; 2022 Apr; 65(4):112-122. PubMed ID: 35106813 [TBL] [Abstract][Full Text] [Related]